Medical Innovation Exchange

Sellas retunes leukemia trial as patients live longer than expected. Is the biotech’s drug behind survival boost?

https://www.fiercebiotech.com/biotech/sellas-retunes-leukemia-trial-patients-live-longer-expected-biotechs-drug-behind-survival

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!